126 related articles for article (PubMed ID: 8587164)
1. [Antimicrobial activities of clavulanic acid/ticarcillin against clinical isolates].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Dec; 48(12):1899-905. PubMed ID: 8587164
[TBL] [Abstract][Full Text] [Related]
2. The antibacterial activity of ticarcillin/clavulanic acid (BRL28500) against ticarcillin-resistant bacteria.
Kasai T; Nishino T; Kazuno Y; Tanino T
J Antibiot (Tokyo); 1986 Oct; 39(10):1450-60. PubMed ID: 3536827
[TBL] [Abstract][Full Text] [Related]
3. [Antimicrobial activities of clavulanic acid/amoxicillin against freshly isolated clinical strains from outpatients].
Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
Jpn J Antibiot; 1995 Dec; 48(12):1920-34. PubMed ID: 8587166
[TBL] [Abstract][Full Text] [Related]
4. [Effect of a ticarcillin-clavulanic acid (timentin) combination on bacteria resistant to ticarcillin].
Rouhan D; Le Noc P; Robert J
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):461-5. PubMed ID: 3937121
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
Hsueh PR; Chang SC; Chen YC; Hsu LY; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
[TBL] [Abstract][Full Text] [Related]
6. [In vitro study of the effects of a ticarcillin-clavulanic acid combination on Pseudomonas aeruginosa as a function of resistant phenotypes].
Thabaut A; Meyran M
Pathol Biol (Paris); 1985 May; 33(5):408-11. PubMed ID: 3929218
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of a ticarcillin-clavulanic acid combination in severe infections in adults].
Lacut JY; Quentin C; Cardoso-Mendes I; Dupon M
Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):591-5. PubMed ID: 3937132
[TBL] [Abstract][Full Text] [Related]
8. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. I. The combined effect of arbekacin with fosfomycin or clavulanic acid/ticarcillin].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Aug; 45(8):949-57. PubMed ID: 1433901
[TBL] [Abstract][Full Text] [Related]
9. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
Traub WH; Spohr M
Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
[TBL] [Abstract][Full Text] [Related]
10. In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.
Gould IM; Dent J; Wise R
J Antimicrob Chemother; 1987 Mar; 19(3):307-12. PubMed ID: 3106304
[TBL] [Abstract][Full Text] [Related]
11. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
Campos P; Vera A; Martin-Luengo F
Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
[No Abstract] [Full Text] [Related]
12. [In vitro activity of the combination ticarcillin-clavulanic acid on bacterial isolates in surgery].
Branger C; Kitzis M; Le Mée J
Pathol Biol (Paris); 1986 Apr; 34(4):245-8. PubMed ID: 3528998
[TBL] [Abstract][Full Text] [Related]
13. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa.
Klepser ME; Marangos MN; Zhu Z; Nicolau DP; Quintiliani R; Nightingale CH
Antimicrob Agents Chemother; 1997 Feb; 41(2):435-9. PubMed ID: 9021203
[TBL] [Abstract][Full Text] [Related]
15. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
Aubert G; Dorche G; Frere A; Raby N; Denis M
Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
[TBL] [Abstract][Full Text] [Related]
16. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
Stobberingh EE
J Antimicrob Chemother; 1988 Jan; 21(1):9-16. PubMed ID: 3128523
[TBL] [Abstract][Full Text] [Related]
17. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
Clarke AM; Zemcov SJ
J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
[TBL] [Abstract][Full Text] [Related]
18. Ticarcillin/clavulanic acid: determination of minimal inhibitory concentrations against bacterial strains isolated from patients in intensive care units. Comparison with other agents.
Pasargiklian I; Lusco G; Paizis G; Mascheroni E
J Chemother; 1996 Apr; 8(2):113-21. PubMed ID: 8708742
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of ticarcillin plus clavulanic acid (BRL 28500, 'Timentin') against ticarcillin-resistant gram-negative rods.
Chattopadhyay B; Hall I
Curr Med Res Opin; 1984; 9(3):157-60. PubMed ID: 6568146
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of ticarcillin with and without clavulanic acid against clinical isolates of gram-positive and gram-negative bacteria.
Pulverer G; Peters G; Kunstmann G
J Antimicrob Chemother; 1986 May; 17 Suppl C():1-5. PubMed ID: 3636325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
